Biotech firm Atomwise used this deck to raise $123m in its series B roundMar 23, 2021 | Funding Atomwise uses deep learning AI technology for structure-based drug discovery. Source link How useful was this post? Click on a star to rate it! Submit Rating Average rating 0 / 5. Vote count: 0 No votes so far! Be the first to rate this post.